In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2059-2071

  Wong, Joseph K ^a,d   Ignacio, Caroline C ^a   Torriani, Francesca ^a,c   Havlir, Diane ^a,b,c   Fitch, Nicholas J S ^a,b   Richman, Douglas D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c San Diego AIDS Treatment Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EPITOPE; LAMIVUDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POL PROTEIN; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; EVOLUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LYMPHOCYTE COUNT; PHYLOGENY; PRIORITY JOURNAL; PROVIRUS; TISSUE SPECIFICITY; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0031041375     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2059-2071.1997     Document Type: Article

References (48)

1. Cleland, A., H. G. Watson, P. Robertson, C. A. Ludlam, and A. J. L. Brown. 1996. Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients. Acquired Immune Defic. Syndr. 126:6-18.
2. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:143-164.
3. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
4. Day, J. J., I. Grant, J. H. Atkinson, L. T. Brysk, J. A. McCutchan, J. R. Hesselink, R. K. Heaton, J. D. Weinrich, S. A. Spector, and D. D. Richman. 1992. Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort. J. Neuropsychiatry Clin. Neurosci. 4:15-20.
5. de Jong, M. D., C. A. B. Boucher, G. J. Galasso, M. S. Hirsch, E. R. Kern, J. M. A. Lange, and D. D. Richman. 1996. Consensus symposium on combined antiviral therapy. Antiviral Res. 29:5-29.
6. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:225-231.
7. Di Stefano, M., F. Sabri, T. Leitner, B. Svennerholm, L. Hagberg, G. Norkrans, and F. Chiodi. 1995. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J. Clin. Microbiol. 33:352-355.
8. Eigen, M., C. K. Biebricher, E. Domingo, J. Holland, and P. Ahlquist (ed.). 1988. Sequence space and quasispecies distribution, p. 212-245. In RNA genetics. CRC Press. Boca Raton, Fla.
9. Epstein, L. G., C. Kuiken, B. M. Blumberg, S. Hartman, L. R. Sharer, M. Clement, and J. Goudsmit. 1991. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 180:583-590.
10. Fitzgibbon, J. E., S. Mazar, and D. T. Dubin. 1993. A new type of G-A hypermutation effecting human immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:833-838.
11. Haggerty, S., and M. Stevenson. 1991. Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol. 4:123-131.
12. Havlir, D. V., and D. D. Richman. 1996. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann. Intern. Med. 124: 984-994.
13. Hosmalin, A., M. Clerici, R. Houghten, C. D. Pendleton, C. Flexner, D. R. Lucey, B. Moss, R. N. Germain, G. M. Shearer, and J. A. Berzofsky. 1990. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 87:2344-2348.
14. Jassoy, C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-I specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
15. Kellam, P., and B. A. Larder. 1994. Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 38:23-30.
16. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
17. Korber, B., C. Brander, B. D. Walker, R. Koup, J. P. Moore, B. Haynes, and G. Myers (ed.). 1995. HIV molecular immunology database 1995. Los Alamos National Laboratory, Los Alamos, N.Mex.
18. Korber, B. T. M., K. J. Kunstman, B. K. Patterson, M. Furtado, M. M. McEvilly, R. Levy, and S. M. Wolinsky. 1994. Genetic differences between blood-and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68:7467-7481.
19. Koyanagi, Y., S. Miles, R. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
20. Kozal, M. J., N. Shah, N. Shen, R. Yang, R. Fucini, T. C. Merigan, D. D. Richman, D. Morris, E. Hubbell, M. Chee, and T. R. Gingeras. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2:753-759.
21. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1992. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:875-885.
22. Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-3985.
23. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, 'N.Y.
24. McGavin, C. H., S. A. Land, K. L. Sebire, D. J. Hooker, A. D. Gurusinghe, and C. J. Birch. 1996. Syncytium-inducing phenotype and zidovudine susceptibility of HIV-1 isolated from post-mortem tissue. AIDS 10:47-53.
25. McMichael, A. J., and B. D. Walker. 1994. Cytotoxic T lymphocytes epitopes: implications for HIV vaccine. AIDS 8(Suppl.):S155-S173.
26. Mellors, J. W., B. A. Larder, and R. F. Schinazi. 1996. Human retroviruses and AIDS, p. III-93-III-106. Los Alamos National Laboratory, Los Alamos, N. Mex.
27. Michael, N. L., G. Chang, P. K. Ehrenberg, M. T. Vahey, and R. R. Redfield. 1993 HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J. Acquired Immune Defic. Syndr. 6:1073-1085.
28. Nájera, I., A. Holguín, M. E. Quiñones-Mateu, M. A. Muñoz-Fernández, R. Nájera, C. López-Galíndez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
29. Pang, S., H. V. Vinters, T. Akashi, W. A. O'Brien, and I. S. Y. Chen. 1991. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. Acquired Immune Defic. Syndr. 4:1082-1092.
30. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. USA 87:6019-6023.
31. Pizzo, P. A., J. Eddy, J. Falloon, F. M. Balis, R. F. Murphy, H. Moss, P. Wolters, P. Brouwers, P. Jarosinski, M. Rubin, S. Broder, R. Yarchoan, A. Brunetti, M. Maha, S. Nusinoff-Lehrman, and D. G. Poplack. 1988. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N. Engl. J. Med. 319:889-896.
32. Portegies, P. 1995. Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC). Drugs 49(Suppl. 1):23-29.
33. Power, C., J. C. McArthur, R. T. Johnson, D. E. Griffin, J. D. Glass, S. Perryman, and B. Chesebro. 1994. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68:4643-4649.
34. Reddy, R. T., A. D. Alexa, A. Sirko, S. Tehranchi, F. G. Kraus, F. Wong-Staal, C. A. Wiley, and HIV Neurobehavioral Research Group. 1996. Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res. Hum. Retroviruses 12:477-482.
35. Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignacio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Barringer, D. Pauletti, C.-K. Shih, M. Myers, and J. Griffin. 1994. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666.
36. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
37. Schmitt F. A., J. W. Bigley, R. McKinnis, P. E. Logue, R. W. Evans, J. L. Drucker, and the AZT Collaborative Working Group. 1988. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 319:1573-1578.
38. Sei, S., D. E. Kleiner, J. B. Kopp, R. Chandra, P. E. Klotman, R. Yarchoan, P. A. Pizzo, and H. Mitsuya. 1994. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. J. Infect. Dis. 170:325-333.
39. Sidtis, J. J., C. Gatsonis, R. W. Price, E. J. Singer, A. C. Collier, D. D. Richman, M. S. Hirsch, F. W. Schaerf, M. A. Koch, J. Feinberg, O. Dafni, and the AIDS Clinical Trials Group. 1993. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann. Neurol. 33:343-349.
40. Sutton, J., S. Rowland-Jones, W. Rosenberg, D. Nixon, F. Gotch, Z. Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith, A. Willis, and A. McMichael. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447-453.
41. Vago, L., A. Castagna, A. Lazzarin, G. Trabattoni, P. Cinque, and G. Costanzi. 1993. Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine. J. Acquired Immune Defic. Syndr. 6:42-45.
42. Vartanian, J.-P., A. Meyerhans, B. Asjo, and S. Wain-Hobson. 1991. Selection, recombination, and G-A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
43. Wildemann, B., J. Haas, K. Ehrhart, M. Hahn, H. Wagner, N. Lynen, and B. Storch-Hagenlocher. 1993. In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients. Neurology 43:2659-2663.
44. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
45. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kuntsman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and et al. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
46. Wright, S. 1977. Evolution and the genetics of populations, p. 443. University of Chicago Press, Chicago, III.
47. Yarchoan, R., C. F. Perno, R. V. Thomas, R. W. Klecker, J. P. Allain, R. J. Wills, N. McAtee, M. A. Fischl, R. Dubinsky, M. C. McNeely, H. Mitsuya, J. M. Pluda, T. J. Lawley, M. D. Leuther, B. Safai, J. M. Collins, C. E. Myers, and S. Broder. 1988. Phase studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet i:76-81.
48. Yarchoan, R., J. M. Pluda, R. V. Thomas, H. Mitsuya, P. Brouwers, K. M. Wyvill, N. Hartman, D. G. Johns, and S. Broder. 1990. Long-term toxicity/ activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet 2:526-529.